Urinary markers have received a lot of attention in recent prostate cancer screenings as a supplement to serum PSA levels to avoid tissue biopsies, as a complementary tool to biopsy analysis, or even as a gold standard method that completely substitutes the biopsy procedure.47, 48, 49. This evidence concerns the gene KLK3 and prostate cancer.